Skip to main content
TipRanks
Go Ultimate75% OFF

Rohto Pharmaceutical Co (4527N) Q1 2025 Earnings Report

0 Followers

MX:4527N Q1 2025 EPS Results

Actual EPS
MXN 6.06
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
MXN 4.32

MX:4527N Q1 2025 Revenue Results

Actual Revenue
MXN 9.53B
Expected Revenue
MXN 9.11B
Beat/Miss
Beat by +MXN 415.07M
YoY Revenue Growth
+19.91%

Earnings Announcement Details

Quarter
Q1 2025
Date
08/06/2025
Time
TBA
Conference Call
Wednesday, August 6, 2025
MX:4527N Upcoming Earnings

Rohto Pharmaceutical Co's next earnings date is estimated for February 12, 2027, based on past reporting schedules.

Q1 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2025 Earnings Slide Deck

Q1 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:4527N Earnings History

MX:4527N earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 12, 20272026 (Q3)6.08-5.47――
Nov 12, 20262026 (Q2)3.803.023.03-0.35% (-0.01)
Aug 06, 20262026 (Q1)4.635.486.06-9.50% (-0.58)
May 13, 20262025 (Q4)3.533.073.18-3.54% (-0.11)
Feb 12, 20262025 (Q3)5.135.476.06-9.71% (-0.59)
Nov 13, 20252025 (Q2)2.903.032.2633.76% (+0.76)
Aug 06, 20252025 (Q1)―6.064.3240.10% (+1.73)
May 13, 20252024 (Q4)2.903.182.4430.69% (+0.75)
Feb 12, 20252024 (Q3)5.716.064.8724.26% (+1.18)
Nov 13, 20242024 (Q2)4.082.263.82-40.83% (-1.56)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed